Vivos Inc to Present at The 13th Annual LD Micro Main Event Conference December 15, 2020 11:00 AM Eastern Standard Time
07 déc. 2020 09h30 HE
|
Vivos Inc.
Richland WA, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL``), Vivos Inc (RDGL), a company that has developed an Yttrium-90 based injectable brachytherapy device, for the treatment of...
Vivos Inc Extends it Intellectual Property Protection
01 déc. 2020 09h30 HE
|
Vivos Inc.
Richland WA, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that it received the Patent Cooperation Treaty (PCT) International Search Report on our patent...
Vivos Inc Applies for Breakthrough Device Designation for Radiogel™
20 nov. 2020 09h30 HE
|
Vivos Inc.
Richland WA, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced that it has completed its submission to the FDA seeking Breakthrough Device Designation for Radiogel™. ...
Vivos Inc Reports Additional IsoPet Therapies
30 juil. 2020 07h00 HE
|
Vivos Inc.
Richland WA, July 30, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Interest in IsoPet therapy is increasing. Yesterday Vivos Inc treated “Mister Motto” a cat that the pet parents flew to the...
Vivos Inc Receives Grant of Protection for RadioGel™ Therapy in China
22 juil. 2020 07h00 HE
|
Vivos Inc.
Richland WA, July 22, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos announced it received the Grant of Protection for the Radiogel™ trademark application in China. The mark is now...
Vivos Inc Achieves Important Radiogel™ Development Milestones
24 juin 2020 07h30 HE
|
Vivos Inc.
Richland WA, June 24, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos announced today significant progress in its efforts to advance RadioGel™ for human therapy. Animal testing at the...
Vivos Inc Expands its Intellectual Property Protection
10 juin 2020 07h00 HE
|
Vivos Inc.
Richland WA, June 10, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos announced that is has submitted an international application based on its patent submittal last June. This is part of...
Vivos Inc Resumes IsoPet Animal Cancer Therapy
29 mai 2020 07h00 HE
|
Vivos Inc.
Richland WA, May 29, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc Resumes IsoPet Animal Cancer Therapy After several months of virus-related stand-down IsoPet therapy has been...
Vivos Inc. Provides 2019 Recap and Outlines 2020 Objectives
13 janv. 2020 07h30 HE
|
Vivos Inc.
Richland WA, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), provides 2019 recap and outlines future objectives. Vivos’ CEO, Dr. Mike Korenko stated, “as we begin 2020, I think it is...
Vivos Inc. Treats Additional Patients at its Pilot Clinic
03 déc. 2019 07h00 HE
|
Vivos Inc.
Richland WA, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) today announced that two dogs with different cancer types were treated using Vivos Inc.’s Isopet® therapy on November 27 at...